Fuller & Thaler Asset Management
ZBH icon

Fuller & Thaler Asset Management’s Zimmer Biomet ZBH Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,236
Closed -$141K – 742
2015
Q1 		$141K Sell
1,236
-206
-14% -$23.5K ﹤0.01% 457
2014
Q4 		$159K Buy
1,442
+206
+17% +$21.7K 0.01% 420
2014
Q3 		$121K Sell
1,236
-309
-20% -$30.4K 0.01% 505
2014
Q2 		$156K Hold
1,545
– – 0.01% 493
2014
Q1 		$142K Sell
1,545
-618
-29% -$57K 0.01% 523
2013
Q4 		$196K Hold
2,163
– – 0.01% 403
2013
Q3 		$172K Hold
2,163
– – 0.01% 398
2013
Q2 		$157K Buy
+2,163
New +$162K 0.01% 394

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management's ZBH Position: Q2 2015 in Review

Fuller & Thaler Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 1,236 shares — an estimated $141K sold.

Fuller & Thaler Asset Management first reported a position in ZBH in Q2 2013 and held it in 8 quarters. The position peaked at $196K in Q4 2013. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

  • Fuller & Thaler Asset Management reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 1,236 Zimmer Biomet shares in Q2 2015, an estimated $141K.
  • Fuller & Thaler Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 8 quarters.
  • Fuller & Thaler Asset Management's Zimmer Biomet position peaked at $196K in Q4 2013.
  • 749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2015, filed 17 Aug 2015.